Interpreting the international trends in testicular seminoma and nonseminoma incidence

Nature Clinical Practice Urology

Volumn 3, Issue 10, 2006, Pages 532-543

  Bray, Freddie ^a   Ferlay, Jacques ^b   Devesa, Susan S ^c   McGlynn, Katherine A ^c   Møller, Henrik ^d  

^a CANCER REGISTRY OF NORWAY   (Norway)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c NATIONAL CANCER INSTITUTE   (United States)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

CANCER CLASSIFICATION; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER INCIDENCE; CANCER REGISTRY; CARCINOGENESIS; CLINICAL FEATURE; COHORT ANALYSIS; DATA ANALYSIS; DEVELOPED COUNTRY; DEVELOPING COUNTRY; ETHNOLOGY; EVIDENCE BASED MEDICINE; GEOGRAPHIC DISTRIBUTION; GERM CELL TUMOR; HUMAN; MALE; PRIORITY JOURNAL; REVIEW; SEMINOMA; SYMPTOMATOLOGY; TESTIS CANCER; TESTIS NONSEMINOMA CANCER; WESTERN HEMISPHERE;

COHORT EFFECT; HUMANS; INCIDENCE; INFERTILITY, MALE; INTERNATIONALITY; MALE; RISK FACTORS; SEMINOMA; SURVIVAL RATE; TESTICULAR NEOPLASMS; WORLD HEALTH;

EID: 33749582205     PISSN: 17434270     EISSN: 17434289     Source Type: Journal    
DOI: 10.1038/ncpuro0606     Document Type: Review

References (52)

1. Moller H and Evans H (2003) Epidemiology of gonadal germ cell cancer in males and females. APMIS 111: 43-46
2. Looijenga LH and Oosterhuis JW (2002) Pathobiology of testicular germ cell tumors: Views and news. Anal Quant Cytol Histol 24: 263-279
3. Moller H et al. (1993) Survival of Danish cancer patients 1943-1987. Male genital organs. APMIS Suppl 33: 122-136
4. Schmoll HJ et al. (2004) European consensus on diagnosis and treatment of germ cell cancer: A report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol 15: 1377-1399
5. Moller H (1993) Clues to the aetiology of testicular germ cell tumours from descriptive epidemiology. Eur Urol 23: 8-13
6. Skakkebaek NE et al. (1987) Carcinoma-in-situ of the testis: Possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl 10: 19-28
7. Rorth M et al. (2000) Carcinoma in situ in the testis. Scand J Urol Nephrol Suppl 205: 166-186
8. Dieckmann KP and Pichlmeier U (2004) Clinical epidemiology of testicular germ cell tumors. World J Urol 22: 2-14
9. Giwercman A et al. (1989) Prevalence of carcinoma in situ and other histopathological abnormalities in testes of men with a history of cryptorchidism. J Urol 142: 998-1001
10. Giwercman A et al. (1991) Prevalence of carcinoma in situ and other histopathological abnormalities in testes from 399 men who died suddenly and unexpectedly. J Urol 145: 77-80
11. Dieckmann KP and Loy V (1998) The value of the biopsy of the contralateral testis in patients with testicular germ cell cancer: The recent German experience. APMIS 106: 13-20
12. Linke J et al. (2005) Prevalence of testicular intraepithelial neoplasia in healthy males. J Urol 173: 1577-1579
13. Parkin DM et al. (2002) Cancer Incidence in Five Continents Vol VIII. Lyon: IARCPress
14. Huyghe E et al. (2003) Increasing incidence of testicular cancer worldwide: A review. J Urol 170: 5-11
15. Moller H (1989) Decreased testicular cancer risk in men born in wartime. J Natl Cancer Inst 81: 1668-1669
16. Wanderas EH et al. (1995) Trends in incidence of testicular cancer in Norway 1955-1992. Eur J Cancer 31A: 2044-2048
17. Bergstrom R et al. (1996) Increase in testicular cancer incidence in six European countries: A birth cohort phenomenon. J Natl Cancer Inst 88: 727-733
18. Richiardi L et al. (2004) Testicular cancer incidence in eight northern European countries: Secular and recent trends. Cancer Epidemiol Biomarkers Prev 13: 2157-2166
19. Moller H (2001) Trends in incidence of testicular cancer and prostate cancer in Denmark. Hum Reprod 16: 1007-1011
20. Hemminki K and Li X (2004) Familial risk in testicular cancer as a clue to a heritable and environmental aetiology. Br J Cancer 90: 1765-1770
21. Hemminki K and Li X (2002) Cancer risks in Nordic immigrants and their offspring in Sweden. Eur J Cancer 38: 2428-2434
22. Ekbom A et al. (2003) Age at immigration and duration of stay in relation to risk for testicular cancer among Finnish immigrants in Sweden. J Natl Cancer Inst 95: 1238-1240
23. Holford TR (1998) Age-period cohort analysis. In Encyclopedia of Biostatistics, 82-99 (Ed Armitage P and Colton T) Chichester: John Wiley & Sons
24. Levi F et al. (2003) Trends in testicular cancer incidence in Vaud, Switzerland. Eur J Cancer Prev 12: 347-349
25. Purdue MP et al. (2005) International patterns and trends in testis cancer incidence. Int J Cancer 115: 822-827
26. Henderson BE et al. (1979) Risk factors for cancer of the testis in young men. Int J Cancer 23: 598-602
27. Ross RK et al. (1979) Descriptive epidemiology of testicular and prostatic cancer in Los Angeles. Br J Cancer 39: 284-292
28. Garner MJ et al. (2005) Epidemiology of testicular cancer: An overview. Int J Cancer 116: 331-339
29. Akre O et al. (1996) Testicular nonseminoma and seminoma in relation to perinatal characteristics. J Natl Cancer Inst 88: 883-889
30. Wanderas EH et al. (1998) Maternal health and pre- and perinatal characteristics in the etiology of testicular cancer: A prospective population- and register-based study on Norwegian males born between 1967 and 1995. Cancer Causes Control 9: 475-486
31. Sabroe S and Olsen J (1998) Perinatal correlates of specific histological types of testicular cancer in patients below 35 years of age: A case-cohort study based on midwives' records in Denmark. Int J Cancer 78: 140-143
32. Richiardi L et al. (2002) Perinatal determinants of germ-cell testicular cancer in relation to histological subtypes. Br J Cancer 87: 545-550
33. Moller H and Skakkebaek NE (1999) Risk of testicular cancer in subfertile men: Case-control study. BMJ 318: 559-562
34. Jacobsen R et al. (2000) Risk of testicular cancer in men with abnormal semen characteristics: Cohort study. BMJ 321: 789-792
35. Skakkebaek NE et al. (1998) Germ cell cancer and disorders of spermatogenesis: An environmental connection? APMIS 106: 3-11
36. Skakkebaek NE et al. (2001) Testicular dysgenesis syndrome: An increasingly common developmental disorder with environmental aspects. Hum Reprod 16: 972-978
37. Henderson BE et al. (1982) Endogenous hormones as a major factor in human cancer. Cancer Res 42: 3232-3239
38. Depue RH et al. (1983) Estrogen exposure during gestation and risk of testicular cancer. J Natl Cancer Inst 71: 1151-1155
39. Sharpe RM and Skakkebaek NE (1993) Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet 341: 1392-1395
40. Aitken RJ et al. (2004) Seeds of concern. Nature 432: 48-52
41. Schwartz GG (2002) Hypothesis: Does ochratoxin A cause testicular cancer? Cancer Causes Control 13: 91-100
42. Hardell L et al. (2003) Increased concentrations of polychlorinated biphenyls, hexachlorobenzene, and chlordanes in mothers of men with testicular cancer. Environ Health Perspect 111: 930-934
43. Hardell L et al. (2004) Concentrations of polychlorinated biphenyls in blood and the risk for testicular cancer. Int J Androl 27: 282-290
44. Surveillance Epidemiology and End Results (SEER) Program (2004) SEER Stat Database: Incidence - SEER 9 Regs Public-Use (1973-2001). National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, Bethedsa
45. Steinitz R et al. (1989) Cancer Incidence in Jewish Migrants to Israel 1961-1981. Lyon: IARC
46. European Network of Cancer Registries (2001) EUROCIM Version 4.0: European incidence database V2.4, CI5 dictionary. Lyon: IARC
47. Percy C et al. (1990) International Classification of Diseases for Oncology, edn 2. Geneva: World Health Organization
48. Parkin DM et al. (1992) Cancer Incidence in Five Continents Vol VI. Lyon: IARCPress
49. Parkin DM et al. (1997) Cancer Incidence in Five Continents Vol VII. Lyon: IARCPress
50. Parkin DM et al. (1998) Histological Groups for Comparative Studies. Lyon: IARC
51. Doll R and Cook P (1967) Summarizing indices for comparison of cancer incidence data. Int J Cancer 2: 269-279
52. Segi M and Kurihara M (1960) Cancer Mortality for Selected Sites in 24 Countries (1950-1957). Sendai, Japan: Tohoku University of Medicine